Anterior Chamber Flare as an Objective and Quantitative Noninvasive Method for Oculopathy in Transthyretin V30M Amyloidosis Patients

Table 1

Demographic and clinical data of ATTRV30M patients.

Characteristics	ATTRV30M patients ()
Age, years	46.9 ± 5.6
Male/female	60.7%/39.3%
Time of ATTRV30M diagnosis, years	14.6 ± 3.9
Liver transplantation, %	96.4%
Time from liver transplantation, years	12.3 ± 3.4
Patients under tafamidis treatment,	1